Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 47335-860

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 47335-860). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tramadol-figure1 (Tramadol Figure1)

A line graph comparing plasma concentration levels over 24 hours for Tramadol Hydrochloride extended-release tablets 200 mg once daily, and immediate-release Tramadol tablets 50 mg every 6 hours. The y-axis shows Tramadol concentration in ng/mL, and the x-axis shows time in hours. The graph illustrates differences in drug concentration profiles between the two formulations.*

FDA Label Image

Tramadol-figure2 (Tramadol Figure2)

A pharmacokinetic line graph comparing M1 concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Immediate Release (IR) Tablets 50 mg every 6 hours. The y-axis shows M1 concentration from 0 to 120 ng/mL, and the x-axis shows time in hours from 0 to 24.*

FDA Label Image

Tramadol-figure3 (Tramadol Figure3)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing percent of patients achieving various response thresholds (percent improvement from baseline) on the x-axis versus percent of patients achieving response on the y-axis. It compares Tramadol Hydrochloride extended-release tablets at doses of 100 mg, 200 mg, 300 mg, 400 mg, and placebo, illustrating response rates across thresholds from 0 to 100 percent.*

FDA Label Image

Tramadol-figure4 (Tramadol Figure4)

Line graph showing the percent of patients achieving various levels of response threshold (percent improvement from baseline) in Study 015 for Tramadol Hydrochloride Extended-Release Tablets compared to placebo. The graph’s y-axis represents percent of patients achieving response, and the x-axis represents response thresholds from 0% to 100%. The curve for Tramadol Hydrochloride shows higher patient response rates across thresholds than placebo.*

FDA Label Image

Tramadol-label-100mg (Tramadol Label 100mg)

Label for Tramadol Hydrochloride Extended-Release Tablets 100 mg by Sun Pharmaceutical Industries, Inc. The label specifies a 30-tablet prescription pack with instructions to swallow tablets whole without splitting or crushing. It includes an NDC code 47335-859-83 and a barcode.*

FDA Label Image

Tramadol-label-200mg (Tramadol Label 200mg)

Label for Tramadol Hydrochloride Extended-Release Tablets 200 mg, oral dosage form, supplied in a package containing 30 tablets. The label includes usage instructions, storage conditions, and warnings. Manufactured by Sun Pharmaceutical Industries Ltd., distributed by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Tramadol-label-300mg (Tramadol Label 300mg)

Label for Tramadol Hydrochloride Extended-Release Tablets 300 mg by Sun Pharmaceutical Industries, Inc., distributed in Cranbury, NJ. The label states the tablets should be swallowed whole and provides storage instructions (20° to 25°C). The package contains 30 tablets and is marked Rx only. Manufactured by Sun Pharmaceutical Industries Ltd., Gujarat, India.*

FDA Label Image

Tramadol-structure (Tramadol Structure)

Chemical structure of tramadol hydrochloride, showing its molecular framework with a cyclohexane ring, methoxy-substituted aromatic ring, and dimethylamino group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.